Quarterly report pursuant to Section 13 or 15(d)

Condensed Financial Statements (Details)

v3.10.0.1
Condensed Financial Statements (Details) - USD ($)
 3 Months Ended 9 Months Ended
Aug. 31, 2018
Aug. 31, 2017
Aug. 31, 2018
Aug. 31, 2017
Nov. 30, 2017
Dec. 07, 2016
Nov. 30, 2016
Prior Period Restatement Condensed Financial Statements 55     $ 174,038        
Prior Period Restatement Condensed Financial Statements 56     249,404        
Secured convertible debentures, net of deferred financing costs $ 0   0   $ 892,176    
Prior Period Restatement Condensed Financial Statements 57     (664,413)        
Derivative Liability 290,382   290,382   539,860 $ 285,612  
Prior Period Restatement Condensed Financial Statements 58     (718,667)        
Total Liabilities 1,553,136   1,553,136   1,865,734    
Accumulated deficit (32,057,536)   (32,057,536)   (31,098,864)    
Total Stockholders' Deficiency (381,337) $ (2,005,613) (381,337) $ (2,005,613) $ 326,623   $ (993,592)
Selling, general and administration 385,556 433,759 1,091,424 1,544,953      
Total Operating Expenses 386,870 531,254 1,087,897 1,660,759      
Loss from Operations (362,915) (507,606) (1,016,297) (1,572,790)      
Change in fair value of derivative liabilities 307,201 122,967 245,852 718,667      
Accretion 29,991 94,134 88,102 249,405      
Other expense-Interest 32,946 82,928 100,125 279,729      
Loss before Income Taxes (118,651) (561,701) (958,672) (1,383,257)      
Net loss for the period (118,651) (561,701) (958,672) (1,383,257)      
Comprehensive Loss $ (123,573) $ (559,639) $ (965,847) $ (1,359,399)      
Loss per share - basic and diluted $ (0.001) $ (0.010) $ (0.010) $ (0.024)      
Foreign currency translation (gain) loss     $ 17,498 $ (73,210)      
Net cash used in operating activities     $ (1,057,996) (1,380,962)      
Prior to Restatement [Member]              
Secured convertible debentures, net of deferred financing costs   $ 1,821,807   1,821,807      
Derivative Liability   224,637   224,637      
Total Liabilities   2,525,321   2,525,321      
Accumulated deficit   (29,659,794)   (29,659,794)      
Total Stockholders' Deficiency   (1,983,537)   (1,983,537)      
Foreign currency translation (gain)   79,535   72,246      
Total Operating Expenses   530,768   1,659,795      
Loss from Operations   (507,120)   (1,571,826)      
Change in fair value of derivative liabilities   157,034   664,413      
Accretion   0   0      
Other expense-Interest   (150,629)   (453,768)      
Loss before Income Taxes   (500,715)   (1,361,181)      
Net loss for the period   (500,715)   (1,361,181)      
Comprehensive Loss   $ (498,653)   $ (1,337,323)      
Loss per share - basic and diluted   $ (0.010)   $ (0.020)      
Net Loss       $ (1,361,181)      
Foreign currency translation (gain) loss       72,246      
Net cash used in operating activities       (1,380,962)      
Restated [Member]              
Secured convertible debentures, net of deferred financing costs   $ 1,596,083   1,596,083      
Derivative Liability   472,592   472,592      
Total Liabilities   2,547,552   2,547,552      
Accumulated deficit   (29,682,025)   (29,682,025)      
Total Stockholders' Deficiency   (2,005,768)   (2,005,768)      
Foreign currency translation (gain)   80,021   73,210      
Total Operating Expenses   531,254   1,660,759      
Loss from Operations   (507,606)   (1,572,790)      
Change in fair value of derivative liabilities   122,967   718,667      
Accretion   (94,134)   (249,405)      
Other expense-Interest   (82,928)   (279,729)      
Loss before Income Taxes   (561,701)   (1,383,257)      
Net loss for the period   (561,701)   (1,383,257)      
Comprehensive Loss   $ (559,639)   $ (1,359,399)      
Loss per share - basic and diluted   $ (0.010)   $ (0.022)      
Net Loss       $ (1,383,257)      
Foreign currency translation (gain) loss       73,210      
Net cash used in operating activities       $ (1,380,962)